OncoTICE, Lyophilisat
7680525630383
CH-52563
Lyophilisat
Associated product:
ONCOTICE poudre pour susp intravésicale 500mio U
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Lyophilisat
- Galenic group
- Lösbar zur Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
- | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 122.50
Specialties list
Yes
Generic
No
SL addition date:
15/03/1997
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 52563
- Drug name
- OncoTICE, Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung
- Galenic form
- PULVIV
- ATC Code
- L03AX03
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 16/11/1994
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- ONCOTICE poudre pour suspension intravésicale 1 pc
- Description (DE)
- ONCOTICE Pulver zur Herstellung einer Suspensionen
- Market launch
- 16/11/1994
- Narcotic (BTM)
- No